5DX — Meta Health Income Statement
0.000.00%
Last trade - 00:00
- SG$10.31m
- SG$10.91m
- SG$4.61m
2019 December 31st | 2020 December 31st | R2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 45.5 | 32.2 | 43 | 11.4 | 4.61 |
Cost of Revenue | |||||
Gross Profit | 23 | 15.7 | 20.5 | 1.86 | 0.825 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 44.7 | 33.7 | 41.3 | 18.5 | 7.65 |
Operating Profit | 0.805 | -1.51 | 1.72 | -7.1 | -3.04 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 0.117 | -1.94 | 1.21 | -7.37 | -3.33 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.202 | -1.96 | 1.21 | -7.37 | -3.33 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 0.202 | -1.96 | 1.16 | -8.66 | -8.41 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.202 | -1.96 | 1.16 | -8.66 | -8.41 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0 | -0.004 | -0 | -0.011 | -0.005 |